Motor control testing of upper limb function after botulinum toxin injection: A case study

被引:14
|
作者
Hurvitz, EA [1 ]
Conti, GE
Flansburg, EL
Brown, SH
机构
[1] Univ Michigan, CS Mott Childrens Hosp, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Human Motor Res, Ann Arbor, MI 48109 USA
[3] Eastern Michigan Univ, Dept Associated Htlh Profess, Ypsilanti, MI 48197 USA
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2000年 / 81卷 / 10期
关键词
botulinum toxin type A; muscle spasticity; arm; case report; cerebral palsy; functional assessment; rehabilitation;
D O I
10.1053/apmr.2000.6293
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To evaluate changes in upper extremity function in a hemiparetic patient after treatment with botulinum toxin (BTX) using motor-control testing (MCT) techniques. Design: Interventional with longitudinal study, open label. Setting: A children's hospital and a motor-control laboratory at a major academic center. Participants: A 16-year-old male with right hemiparetic cerebral palsy and a healthy 12-year-old control subject. Interventions: BTX injections to the elbow and wrist flexors. Main Outcome Measures: MCT was used to examine 4 upper extremity movements: forward reach, bilateral rhythmic movements (both muscle homologous and direction homologous), isometric pinch, and hand tapping. The patient was tested before treatment and at 2, 4, 6, 12, 18, and 24 weeks after treatment. In addition, range of motion (ROM), the Ashworth scale of spasticity, Functional Independence Measure(TM), and the mobility and activities of daily living (ADL) sections of the Pediatric Evaluation of the Disability Inventory were performed. Results: Forward reach demonstrated little change initially despite patient reports of "feeling looser." Improvement was noted after 18 weeks, but returned to baseline level at 24 weeks. Bilateral rhythmic movements also showed slight improvement at 18 weeks. Pinch force increased significantly after 2 weeks, but declined again at 6 weeks. Improvements occurred in ROM and the Ashworth rating of spasticity, but were not temporally associated with each other or with MCT results. Functional assessment data did not change during the study period. Conclusions: Improvements in more complex motor tasks were noted after significant delay from the time of treatment, while simpler tasks demonstrated a more rapid improvement, followed by a rapid return to baseline levels. This case suggests that MCT techniques can provide quantitative and qualitative data, which can add new information about upper extremity motor disability and the outcome of treatment.
引用
收藏
页码:1408 / 1415
页数:8
相关论文
共 50 条
  • [11] Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review
    Park, Eun Sook
    Rha, Dong-Wook
    YONSEI MEDICAL JOURNAL, 2006, 47 (05) : 589 - 603
  • [12] Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke
    Childers, MK
    Brashear, A
    Jozefczyk, P
    Reding, M
    Alexander, D
    Good, D
    Walcott, JM
    Jenkins, SW
    Turkel, C
    Molloy, PT
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (07): : 1063 - 1069
  • [13] Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
    Shackley, Phil
    Shaw, Lisa
    Price, Christopher
    van Wijck, Frederike
    Barnes, Michael
    Graham, Laura
    Ford, Gary A.
    Steen, Nick
    Rodgers, Helen
    TOXINS, 2012, 4 (12): : 1415 - 1426
  • [14] Efficacy of botulinum toxin A for the treatment of hemiparesis in adults upper limb spasticity
    Ghroubi, Sameh
    Alila, Samar
    Elleuch, Wafa
    Ben Ayed, Houda
    Mhiri, Chokri
    Elleuch, Mohamed Habib
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [15] Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity
    Yang, TF
    Fu, CP
    Kao, NT
    Chan, RC
    Chen, SJ
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2003, 82 (04) : 284 - 289
  • [16] Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity
    Schwabe, Aloysia L.
    SEMINARS IN PLASTIC SURGERY, 2016, 30 (01) : 24 - 28
  • [17] Effect of Baseline Spastic Hemiparesis on Recovery of Upper-Limb Function Following Botulinum Toxin Type A Injections and Postinjection Therapy
    Chang, Chia-Lin
    Munin, Michael C.
    Skidmore, Elizabeth R.
    Niyonkuru, Christian
    Huber, Lynne M.
    Weber, Douglas J.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2009, 90 (09): : 1462 - 1468
  • [18] Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke
    Amatya, B.
    Lizama, L. E. Cofre
    Elmalik, A.
    Bastani, A.
    Galea, M. P.
    Khan, F.
    NEUROREHABILITATION, 2019, 45 (01) : 67 - 78
  • [19] Limited Evidence of Functional Benefit After Upper Limb Botulinum Toxin Treatment in Children With Cerebral Palsy
    Gresits, Orsolya Zsuzsanna
    Vezer, Matyas
    Engh, Marie Anne
    Szabo, Laszlo
    Molnar, Zsolt
    Hegyi, Peter
    Terebessy, Tamas
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2025, 104 (02) : 108 - 116
  • [20] Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: A case series
    Charrow, Alexandra
    DiFazio, Marc
    Foster, Leslie
    Pasquina, Paul F.
    Tsao, Jack W.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (07): : 1407 - 1409